Debby Ben-David
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
- Epidemiology 11
- Urinary Tract Infections Management 6
- Pneumonia and Respiratory Infections 3
-
- Antimicrobial Resistance in Staphylococcus 6
- Co-authors
- Nathan Keller (6 shared papers)Yasmin Maor (9 shared papers)Ilana Tal (3 shared papers)Leonard A. Mermel (4 shared papers)Gill Smollan (5 shared papers)Ohad Gal‐Mor (1 shared paper)Alex Marzel (1 shared paper)G. Rahav (2 shared papers)
- Journals
- Infection Control and Hospital Epidemiology (11 papers)BMC Infectious Diseases (3 papers)Journal of Clinical Microbiology (2 papers)Eurosurveillance (2 papers)Antibiotics (2 papers)
- Partner nations
- IsraelUnited StatesCanada
In The Last Decade
Debby Ben-David
32 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 76
- Molecular Medicine 526
- Applied Microbiology and Biotechnology 173
- Clinical Biochemistry 169
- Critical Care and Intensive Care Medicine 105
- Infectious Diseases 391
Countries citing papers authored by Debby Ben-David
This map shows the geographic impact of Debby Ben-David's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debby Ben-David with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debby Ben-David more than expected).
Fields of papers citing papers by Debby Ben-David
This network shows the impact of papers produced by Debby Ben-David. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debby Ben-David. The network helps show where Debby Ben-David may publish in the future.
Co-authors
The 25 scholars most cited alongside Debby Ben-David, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 279 | |
| 2 | 2016 | 162 | |
| 3 | 2010 | 141 | |
| 4 | 2011 | 80 | |
| 5 | 2009 | 70 | |
| 6 | 2008 | 70 | |
| 7 | 2007 | 66 | |
| 8 | 2016 | 39 | |
| 9 | 2010 | 33 | |
| 10 | 2014 | 32 | |
| 11 | 2017 | 32 | |
| 12 | 2007 | 29 | |
| 13 | 2018 | 26 | |
| 14 | 2002 | 16 | |
| 15 | 2006 | 11 | |
| 16 | 2019 | 10 | |
| 17 | 2023 | 9 | |
| 18 | 2022 | 9 | |
| 19 | 2009 | 9 | |
| 20 | 2013 | 9 |
About Debby Ben-David
Debby Ben-David is a scholar working on Epidemiology, Infectious Diseases, Molecular Medicine, Applied Microbiology and Biotechnology and Critical Care and Intensive Care Medicine, having authored 36 papers that have together received 1.2k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (7 papers), Urinary Tract Infections Management (6 papers), Antimicrobial Resistance in Staphylococcus (6 papers), Antibiotic Use and Resistance (4 papers), Pneumonia and Respiratory Infections (3 papers), Nosocomial Infections in ICU (3 papers), Patient Satisfaction in Healthcare (2 papers) and Streptococcal Infections and Treatments (2 papers). The work is most often cited by research in Molecular Medicine (526 citations), Applied Microbiology and Biotechnology (173 citations), Clinical Biochemistry (169 citations), Critical Care and Intensive Care Medicine (105 citations) and Infectious Diseases (391 citations). Debby Ben-David has collaborated with scholars based in Israel, United States and Canada. Frequent co-authors include Nathan Keller, Yasmin Maor, Ilana Tal, Leonard A. Mermel, Gill Smollan, Ohad Gal‐Mor, Alex Marzel, G. Rahav, Yehuda Carmeli and Mitchell J. Schwaber. Their work appears in journals such as Infection Control and Hospital Epidemiology, BMC Infectious Diseases, Journal of Clinical Microbiology, Eurosurveillance and Antibiotics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.